iopromide
Sign in to saveAlso known as Ultravist 150, Ultravist 240, Ultravist 370, ZK-35760, Ultravist, Ultravist 300, N,N'-Bis(2,3-dihydroxypropyl)-2,4,6-triiodo-5-(2-methoxyacetamido)-N-methylisophthalamide
Iopromide is an iodinated contrast medium for X-ray imaging. It is marketed under the name Ultravist which is produced by Bayer Healthcare. It is a low osmolar, non-ionic contrast agent for intravascular use; i.e., it is injected into blood vessels.
Research
2,046 papers- Iopromide and Iodixanol in the Development of Postoperative Contrast Nephropathy in Patients with Renal Insufficiency: A Meta-Analysis.Journal of healthcare engineering · 2022
- [Iopromide-Induced Encephalopathy: A Case Report and Literature Review].Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition · 2021
- Iodixanol versus iopromide in patients with renal insufficiency undergoing coronary angiography with or without PCI.Medicine · 2018
- Iopromide safety assessment in a radiology department: A seven-year retrospective characterization of adverse events.The International journal of risk & safety in medicine · 2024
- Pharmacochemical profile of iopromide.AJNR. American journal of neuroradiology · 1983
via PubMed
~1 min read
Encyclopedic overview
4 sectionsContents
- Medical uses
- Contraindications
- References
- External links
Iopromide is an iodinated contrast medium for X-ray imaging. It is marketed under the name Ultravist which is produced by Bayer Healthcare. It is a low osmolar, non-ionic contrast agent for intravascular use; i.e., it is injected into blood vessels.
It is commonly used in radiographic studies such as intravenous urograms, brain computer tomography (CT) and CT pulmonary angiograms (CTPAs).
Excerpted from Wikipedia’s “iopromide” article, available under the CC BY-SA 4.0 licence.
Available in 8 languages
via Wikidata sitelinks · CC0